Maternus-Kliniken Aktiengesellschaft (F:MAK) — Stock Price
Maternus-Kliniken Aktiengesellschaft (F:MAK) is currently trading at €0.89 EUR, down 1.66% today. Over the past 52 weeks, shares have ranged between €0.84 and €4.26. This page tracks Maternus-Kliniken Aktiengesellschaft's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see how much is Maternus-Kliniken Aktiengesellschaft worth.
Maternus-Kliniken Aktiengesellschaft (MAK) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Maternus-Kliniken Aktiengesellschaft's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.
Maternus-Kliniken Aktiengesellschaft Income Statement — Revenue, Profit & Earnings by Year
Maternus-Kliniken Aktiengesellschaft's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | €114.00 Million | €102.31 Million | €106.70 Million | €111.44 Million | €114.30 Million |
| Cost of Revenue | €15.22 Million | €14.86 Million | €19.72 Million | €13.92 Million | €16.60 Million |
| Gross Profit | €98.78 Million | €87.45 Million | €86.98 Million | €97.52 Million | €97.70 Million |
| Research & Development | — | — | — | — | — |
| SG&A | €4.04 Million | €3.59 Million | €2.96 Million | €3.06 Million | €3.03 Million |
| Total Operating Expenses | €117.99 Million | €111.57 Million | €116.84 Million | €107.67 Million | €112.75 Million |
| Operating Income | €-3.99 Million | €-9.26 Million | €-10.14 Million | €3.76 Million | €1.55 Million |
| EBITDA | — | — | €3.96 Million | €15.16 Million | €11.04 Million |
| EBIT | — | — | €-10.14 Million | €1.11 Million | €259.00K |
| Interest Expense | €8.43 Million | €7.55 Million | €5.78 Million | €6.01 Million | €7.24 Million |
| Income Before Tax | €-10.28 Million | €-12.58 Million | €-12.83 Million | €-1.96 Million | €-7.78 Million |
| Income Tax Expense | — | — | €1.25 Million | €521.00K | €1.84 Million |
| Net Income | €-13.16 Million | €-14.26 Million | €-14.08 Million | €-2.48 Million | €-9.62 Million |
Maternus-Kliniken Aktiengesellschaft Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Maternus-Kliniken Aktiengesellschaft's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | €139.88 Million | €154.38 Million | €153.40 Million | €165.41 Million | €178.63 Million |
| Total Current Assets | €17.02 Million | €23.54 Million | €16.89 Million | €22.69 Million | €20.82 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | €2.06 Million | €9.44 Million | €3.13 Million | €1.08 Million | €1.45 Million |
| Net Receivables | €8.12 Million | €9.22 Million | €4.80 Million | €4.51 Million | €5.33 Million |
| Inventory | €408.00K | €586.00K | €586.00K | €598.00K | €444.00K |
| Property, Plant & Equipment | — | — | €119.23 Million | €128.45 Million | €142.77 Million |
| Goodwill | €13.21 Million | €13.21 Million | €13.21 Million | €13.21 Million | €13.21 Million |
| Total Liabilities | €206.72 Million | €208.14 Million | €192.70 Million | €193.26 Million | €204.03 Million |
| Total Current Liabilities | €132.82 Million | €77.44 Million | €56.33 Million | €47.27 Million | €42.79 Million |
| Long-term Debt | €205.00K | €53.96 Million | €76.35 Million | €76.64 Million | €76.96 Million |
| Net Debt | €109.31 Million | €106.76 Million | €105.03 Million | €87.65 Million | €89.22 Million |
| Total Stockholder Equity | €-66.84 Million | €-53.76 Million | €-39.30 Million | €-27.85 Million | €-25.41 Million |
| Retained Earnings | €-122.02 Million | €-108.86 Million | €-95.00 Million | €-81.05 Million | €-81.11 Million |
Maternus-Kliniken Aktiengesellschaft Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Maternus-Kliniken Aktiengesellschaft generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | €15.07 Million | €2.52 Million | €4.33 Million | €17.24 Million | €12.17 Million |
| Capital Expenditures | €1.22 Million | €3.96 Million | €2.00 Million | €1.91 Million | €712.00K |
| Free Cash Flow | €13.86 Million | €-1.44 Million | €2.33 Million | €15.32 Million | €11.43 Million |
| Investing Cash Flow | — | — | €-2.00 Million | €-1.92 Million | €-702.00K |
| Financing Cash Flow | — | — | €-12.76 Million | €-12.79 Million | €-2.23 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | €12.56 Million | €9.74 Million | €11.02 Million | €11.12 Million | €11.59 Million |
| Change in Cash | €2.32 Million | €-1.51 Million | €-10.43 Million | €2.54 Million | €9.24 Million |
Maternus-Kliniken Aktiengesellschaft Earnings History — EPS Actual vs. Analyst Estimates
Track Maternus-Kliniken Aktiengesellschaft's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Sep 08, 2025 | — | — | — |
| Aug 01, 2007 | -0.04 | -0.01 | -300.00% |